Over 1,750 Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage have applied to offer lower insulin costs through the Part D Senior Savings Model for the 2021 plan year, the Centers for Medicare & Medicaid Services said yesterday.

Announced in March, the five-year model will require participating plans to limit cost sharing for a 30-day supply of insulin to no more than $35. CMS estimates beneficiaries in the plans could save an average $446 (66%) in out-of-pocket costs for insulin, funded in part by manufacturer discounts. Part D sponsors that applied must submit their calendar year 2021 plan benefits to CMS by June 1. CMS expects to release CY 2021 premiums and costs for specific Medicare plans in September, including final information on the model.

Related News Articles

Headline
The Centers for Medicare & Medicaid Aug. 15 announced it negotiated lower prices with drug makers for 10 high-cost, sole-source drugs, with the new prices…
Headline
The AHA, joined by five other national hospital associations, Aug. 14 filed an amicus brief urging the Supreme Court to correct the Department of Health and…
Headline
The AHA Aug. 13 commented to the Medicare Payment Advisory Commission in anticipation of the commission’s 2024-2025 cycle. The AHA urged MedPAC to carefully…
Headline
More than 46 million prior authorization requests were submitted to Medicare Advantage insurers in 2022, according to KFF analysis released Aug. 6 examining…
Headline
The AHA along with the Federation of American Hospitals, America’s Essential Hospitals and the Association of American Medical Colleges July 29 filed an amicus…
Headline
The Centers for Medicare & Medicaid Services July 16 released its final guidance on the Medicare Prescription Payment Plan which will begin next year. The…